In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors

Anna R. Garbuglia, Roberto Salvi, Antonino Di Caro, Giuseppina Cappiello, Francesco Montella, Fiorella Di Sora, Olga Recchia, Filippo Lauria, Arrigo Benedetto

Research output: Contribution to journalArticle

Abstract

Objectives: We investigated a selected group of 11 non-progressor, HIV-infected individuals 20 months prior to this study and found that they all had undetectable levels of viral RNA expression in their peripheral blood lymphocytes (PBL). Phorbol 12-myristate 13-acetate (PMA) and phytohaemagglutinin (PHA) stimulation of PBL produced easily detectable amounts of HIV RNA in only two out of five of these patients. Here we report the results of the virological and clinical follow-up of nine non-progressors from this group. We verified the stability of their non-progressive status and attempted to correlate it to specific virological markers. Methods: Proviral DNA in lymphocytes was tested by semi-quantitative polymerase chain reaction (PCR). Detection of unspliced (US) and multiple spliced (MS) HIV RNA species in unstimulated and stimulated lymphocytes was performed by reverse transcriptase-PCR (RT-PCR). The amount of p24 antigen released into the media of lymphocyte cultures was measured using a standard procedure. Lymphocyte populations were depleted of CD8 cells by immunomagnetic purging. Results: Follow-up of nine of these subjects showed that the patients who previously showed viral RNA activation following lymphocyte stimulation in vitro, developed a clinical and immunological progression characterized by CD4 count decline and lymphadenopathy. In contrast, all the other subjects maintained progression-free status throughout the follow-up period, with no detectable levels of HIV RNA in the PBL. Notably, this group of subjects showed no activation of viral RNA expression following stimulation of either undepleted or CD8-depleted lymphocytes in vitro. Conclusion: The group of non-progressors studied was found to be heterogeneous regarding the stability of the non-progressive status during the follow-up period. Our results suggest that the activation of HIV RNA expression following PMA-PHA treatment of lymphocytes in vitro is an early marker for future progression of the disease.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalAIDS (London, England)
Volume10
Issue number1
Publication statusPublished - 1996

Fingerprint

Survivors
HIV
Lymphocytes
RNA
Viral RNA
Phytohemagglutinins
HIV Long-Term Survivors
Acetates
Immunomagnetic Separation
In Vitro Techniques
Virus Activation
CD4 Lymphocyte Count
Lymphocyte Activation
Reverse Transcriptase Polymerase Chain Reaction
Culture Media
Disease Progression
Antigens
Polymerase Chain Reaction
DNA
Population

Keywords

  • HIV RNA species
  • Non-progressive HIV infection
  • Phorbol 12-myristate 13-acetate
  • Phytohaemagglutinin induction

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors. / Garbuglia, Anna R.; Salvi, Roberto; Di Caro, Antonino; Cappiello, Giuseppina; Montella, Francesco; Di Sora, Fiorella; Recchia, Olga; Lauria, Filippo; Benedetto, Arrigo.

In: AIDS (London, England), Vol. 10, No. 1, 1996, p. 17-21.

Research output: Contribution to journalArticle

Garbuglia, Anna R. ; Salvi, Roberto ; Di Caro, Antonino ; Cappiello, Giuseppina ; Montella, Francesco ; Di Sora, Fiorella ; Recchia, Olga ; Lauria, Filippo ; Benedetto, Arrigo. / In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors. In: AIDS (London, England). 1996 ; Vol. 10, No. 1. pp. 17-21.
@article{d53b12b32b524bfdbe4011f5cbb620e8,
title = "In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors",
abstract = "Objectives: We investigated a selected group of 11 non-progressor, HIV-infected individuals 20 months prior to this study and found that they all had undetectable levels of viral RNA expression in their peripheral blood lymphocytes (PBL). Phorbol 12-myristate 13-acetate (PMA) and phytohaemagglutinin (PHA) stimulation of PBL produced easily detectable amounts of HIV RNA in only two out of five of these patients. Here we report the results of the virological and clinical follow-up of nine non-progressors from this group. We verified the stability of their non-progressive status and attempted to correlate it to specific virological markers. Methods: Proviral DNA in lymphocytes was tested by semi-quantitative polymerase chain reaction (PCR). Detection of unspliced (US) and multiple spliced (MS) HIV RNA species in unstimulated and stimulated lymphocytes was performed by reverse transcriptase-PCR (RT-PCR). The amount of p24 antigen released into the media of lymphocyte cultures was measured using a standard procedure. Lymphocyte populations were depleted of CD8 cells by immunomagnetic purging. Results: Follow-up of nine of these subjects showed that the patients who previously showed viral RNA activation following lymphocyte stimulation in vitro, developed a clinical and immunological progression characterized by CD4 count decline and lymphadenopathy. In contrast, all the other subjects maintained progression-free status throughout the follow-up period, with no detectable levels of HIV RNA in the PBL. Notably, this group of subjects showed no activation of viral RNA expression following stimulation of either undepleted or CD8-depleted lymphocytes in vitro. Conclusion: The group of non-progressors studied was found to be heterogeneous regarding the stability of the non-progressive status during the follow-up period. Our results suggest that the activation of HIV RNA expression following PMA-PHA treatment of lymphocytes in vitro is an early marker for future progression of the disease.",
keywords = "HIV RNA species, Non-progressive HIV infection, Phorbol 12-myristate 13-acetate, Phytohaemagglutinin induction",
author = "Garbuglia, {Anna R.} and Roberto Salvi and {Di Caro}, Antonino and Giuseppina Cappiello and Francesco Montella and {Di Sora}, Fiorella and Olga Recchia and Filippo Lauria and Arrigo Benedetto",
year = "1996",
language = "English",
volume = "10",
pages = "17--21",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors

AU - Garbuglia, Anna R.

AU - Salvi, Roberto

AU - Di Caro, Antonino

AU - Cappiello, Giuseppina

AU - Montella, Francesco

AU - Di Sora, Fiorella

AU - Recchia, Olga

AU - Lauria, Filippo

AU - Benedetto, Arrigo

PY - 1996

Y1 - 1996

N2 - Objectives: We investigated a selected group of 11 non-progressor, HIV-infected individuals 20 months prior to this study and found that they all had undetectable levels of viral RNA expression in their peripheral blood lymphocytes (PBL). Phorbol 12-myristate 13-acetate (PMA) and phytohaemagglutinin (PHA) stimulation of PBL produced easily detectable amounts of HIV RNA in only two out of five of these patients. Here we report the results of the virological and clinical follow-up of nine non-progressors from this group. We verified the stability of their non-progressive status and attempted to correlate it to specific virological markers. Methods: Proviral DNA in lymphocytes was tested by semi-quantitative polymerase chain reaction (PCR). Detection of unspliced (US) and multiple spliced (MS) HIV RNA species in unstimulated and stimulated lymphocytes was performed by reverse transcriptase-PCR (RT-PCR). The amount of p24 antigen released into the media of lymphocyte cultures was measured using a standard procedure. Lymphocyte populations were depleted of CD8 cells by immunomagnetic purging. Results: Follow-up of nine of these subjects showed that the patients who previously showed viral RNA activation following lymphocyte stimulation in vitro, developed a clinical and immunological progression characterized by CD4 count decline and lymphadenopathy. In contrast, all the other subjects maintained progression-free status throughout the follow-up period, with no detectable levels of HIV RNA in the PBL. Notably, this group of subjects showed no activation of viral RNA expression following stimulation of either undepleted or CD8-depleted lymphocytes in vitro. Conclusion: The group of non-progressors studied was found to be heterogeneous regarding the stability of the non-progressive status during the follow-up period. Our results suggest that the activation of HIV RNA expression following PMA-PHA treatment of lymphocytes in vitro is an early marker for future progression of the disease.

AB - Objectives: We investigated a selected group of 11 non-progressor, HIV-infected individuals 20 months prior to this study and found that they all had undetectable levels of viral RNA expression in their peripheral blood lymphocytes (PBL). Phorbol 12-myristate 13-acetate (PMA) and phytohaemagglutinin (PHA) stimulation of PBL produced easily detectable amounts of HIV RNA in only two out of five of these patients. Here we report the results of the virological and clinical follow-up of nine non-progressors from this group. We verified the stability of their non-progressive status and attempted to correlate it to specific virological markers. Methods: Proviral DNA in lymphocytes was tested by semi-quantitative polymerase chain reaction (PCR). Detection of unspliced (US) and multiple spliced (MS) HIV RNA species in unstimulated and stimulated lymphocytes was performed by reverse transcriptase-PCR (RT-PCR). The amount of p24 antigen released into the media of lymphocyte cultures was measured using a standard procedure. Lymphocyte populations were depleted of CD8 cells by immunomagnetic purging. Results: Follow-up of nine of these subjects showed that the patients who previously showed viral RNA activation following lymphocyte stimulation in vitro, developed a clinical and immunological progression characterized by CD4 count decline and lymphadenopathy. In contrast, all the other subjects maintained progression-free status throughout the follow-up period, with no detectable levels of HIV RNA in the PBL. Notably, this group of subjects showed no activation of viral RNA expression following stimulation of either undepleted or CD8-depleted lymphocytes in vitro. Conclusion: The group of non-progressors studied was found to be heterogeneous regarding the stability of the non-progressive status during the follow-up period. Our results suggest that the activation of HIV RNA expression following PMA-PHA treatment of lymphocytes in vitro is an early marker for future progression of the disease.

KW - HIV RNA species

KW - Non-progressive HIV infection

KW - Phorbol 12-myristate 13-acetate

KW - Phytohaemagglutinin induction

UR - http://www.scopus.com/inward/record.url?scp=0030044999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030044999&partnerID=8YFLogxK

M3 - Article

C2 - 8924247

AN - SCOPUS:0030044999

VL - 10

SP - 17

EP - 21

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 1

ER -